Macrophage Membrane-Camouflaged Mesoporous Polydopamine Nanoparticles for Targeted Delivery of Apigenin in Sepsis-Induced Acute Lung Injury.
- 1Department of Anesthesiology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.
Abstract
Introduction
Sepsis-induced acute lung injury (ALI) is a critical illness that poses a serious threat to human health, and effective treatments remain lacking. This study aimed to develop a macrophage membrane-biomimetic nano-delivery system loaded with mesoporous polydopamine (MPDA)-encapsulated apigenin (API) and to investigate its therapeutic potential in ALI.Methods
In this study, we developed a macrophage membrane-coated biomimetic nano-delivery system, designated MEM@MPDA/API nanoparticles (NPs). We first systematically characterized the physicochemical properties of MEM@MPDA/API, and then evaluated its cellular uptake, reactive oxygen species (ROS) scavenging capacity, and mitochondrial function restoration through in vitro experiments. In vivo, after constructing an ALI mouse model, we assessed its active targeting to lung tissue, anti-inflammatory efficacy, pulmonary barrier repair capacity, and tissue safety following tail vein administration.Results
In vivo results demonstrated that MEM@MPDA/API NPs effectively scavenged ROS, reduced inflammatory cytokine levels, and restored mitochondrial function. In the ALI mouse model, these NPs efficiently accumulated in the injured lung regions, alleviated pulmonary histopathological damage, and repaired the alveolar epithelial barrier. Integrated single-cell transcriptomics analysis and network pharmacology studies revealed that mitophagy-related pathways were activated during the progression of ALI.Conclusion
This study proposes a promising biomimetic nano-delivery strategy, providing a safe and efficient potential new approach for the application of biomimetic nanomedicine in the treatment of ALI and oxidative stress-related critical diseases.
Related
- Chemically programmable hybrid membrane-camouflaged acetate gossypol prodrug reprograms the hepatic microenvironment for the treatment of liver fibrosis
- Design meets simplicity: employing anhydrous precursors in microwave synthesis of NaGdF₄:Yb³⁺,Tm³⁺ upconverting nanoparticles and their deposition inside mesoporous titania or silica thin films through spin-coating
- Dual-Functionalized Electrospun PCL Membranes with Polydopamine/Gold Nanoparticles: Cytocompatibility Assessment for a Potential Cardiac Patch
- Spatio-temporal in vivo distribution of core-shell mesoporous silica nanoparticles by label-free X-ray fluorescence imaging
- Ethylene-bridged Periodic Mesoporous Organosilica Nanoparticles: controlling architecture through mechanistic investigations
BibTeX
@article{zhang2026macrophage,
title = {{Macrophage Membrane-Camouflaged Mesoporous Polydopamine Nanoparticles for Targeted Delivery of Apigenin in Sepsis-Induced Acute Lung Injury.}},
author = {Yingying Zhang and Lizhen Huang and Hanghang Han and Siyu Zhou and Wuling Liang and Huiming Chen and Xueke Du},
journal = {International journal of nanomedicine},
year = {2026},
month = oct,
doi = {10.2147/ijn.s618525},
url = {https://europepmc.org/article/MED/42836148},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Macrophage Membrane-Camouflaged Mesoporous Polydopamine Nanoparticles for Targeted Delivery of Apigenin in Sepsis-Induced Acute Lung Injury.
AU - Yingying Zhang
AU - Lizhen Huang
AU - Hanghang Han
AU - Siyu Zhou
AU - Wuling Liang
AU - Huiming Chen
AU - Xueke Du
PY - 2026
DA - 2026/10/01
JO - International journal of nanomedicine
DO - 10.2147/ijn.s618525
UR - https://europepmc.org/article/MED/42836148
AB - Introduction Sepsis-induced acute lung injury (ALI) is a critical illness that poses a serious threat to human health, and effective treatments remain lacking. This study aimed to develop a macrophage membrane-biomimetic nano-delivery system loaded with mesoporous polydopamine (MPDA)-encapsulated apigenin (API) and to investigate its therapeutic potential in ALI.Methods In this study, we developed a macrophage membrane-coated biomimetic nano-delivery system, designated MEM@MPDA/API nanoparticles (NPs). We first systematically characterized the physicochemical properties of MEM@MPDA/API, and then evaluated its cellular uptake, reactive oxygen species (ROS) scavenging capacity, and mitochondrial function restoration through in vitro experiments. In vivo, after constructing an ALI mouse model, we assessed its active targeting to lung tissue, anti-inflammatory efficacy, pulmonary barrier repair capacity, and tissue safety following tail vein administration.Results In vivo results demonstrated that MEM@MPDA/API NPs effectively scavenged ROS, reduced inflammatory cytokine levels, and restored mitochondrial function. In the ALI mouse model, these NPs efficiently accumulated in the injured lung regions, alleviated pulmonary histopathological damage, and repaired the alveolar epithelial barrier. Integrated single-cell transcriptomics analysis and network pharmacology studies revealed that mitophagy-related pathways were activated during the progression of ALI.Conclusion This study proposes a promising biomimetic nano-delivery strategy, providing a safe and efficient potential new approach for the application of biomimetic nanomedicine in the treatment of ALI and oxidative stress-related critical diseases.
SN - 1176-9114
SN - 1178-2013
ER -